SlideShare a Scribd company logo
1 of 8
Good Laboratory Practice
Presented by: Manju Jakhar
M.Pharm (Pharmacology)
2nd Semester
INTRODUCTION
• Good Laboratory Practice (GLP) regulations became part of the regulatory landscape in the
latter part of the 1970s in response to malpractice in research and development (R&D)
activities by pharmaceutical companies and contract facilities used by them.
• The malpractice included cases of fraud, but by far the most important aspects were the lack
of proper management and organization of studies performed to generate data fo regulatory
dossiers. The US Food and Drug Administration (FDA) mounted a series of investigations in
toxicology laboratories throughout the USA. The results of these investigations revealed a
situation that could only be dealt with by imposing binding regulations. These regulations are
the GLP regulations.
• GLP regulations were first instituted by US FDA, then by US Environmental Protection Agency
(EPA) many other nations have since followed suit.
• FDA weekly update their data and they upload on their website.
• In 1981, the Organization for Economic Cooperation and Development (OECD) also published
GLP Principles.
GLP WORK:-
The intent of GLP is to regulate the practices of scientists working on the safety testing of
prospective drugs (and other chemical or biochemical entities).
THE FUNDAMENTAL POINTS OF GLP:-
• The GLP regulations set out the rules for good practice and help researchers perform their
work in compliance with their own pre-established plans and standardized procedures. The
regulations are not concerned with the scientific or technical content of the research
programmes. Nor do they aim to evaluate the scientific value of the studies.
• All GLP texts, irrespective of their origin, stress the importance on the following points five
points:
1. Resources: organization, personnel, facilities and equipment
2. Characterization: test items and test systems
3. Rules: study plans (or protocols) and written procedures
4. Results: raw data, final report and archives
5. Quality Assurance.
The training programme of the WHO covers each of these five fundamental points and explains
the requirements of GLP in each case.
1. Resources
 Organization and personnel
GLP regulations require that the structure of R&D organizations and the responsibilities of R&D
personnel be clearly defined. GLP also stresses that there should be sufficient staff to perform
the tasks required. The qualifications and the training of staff must also be defined and
documented.
 Facilities and equipment
The regulations emphasize the need for sufficient facilities and equipment to perform the
studies. All equipment must be in working order. To ensure this, a strict programme of
qualification, calibration and maintenance must be adopted.
2. Characterization
In order to perform a study correctly, it is essential to know as much as possible about the
materials used during the study. For studies that evaluate the properties of pharmaceutical
compounds during non-clinical studies, it is a prerequisite to have details about the test item
and the test system (often an animal or plant) to which the test item is to be administered.
3. Rules
 Protocols and written procedures
The main steps of research studies are prescribed in the study plan or protocol. Being able to
repeat studies and obtain similar results is a sine qua non of mutual acceptance of data and,
indeed, a central tenet of the scientific method, so the details of routine procedures must also
be available to scientists involved in the study. However, the protocol, which provides the
experimental design and timeframe for the study, does not contain all the technical detail
necessary to conduct the study. These details are found in written standard operating
procedures (SOPs). With the protocol and the SOPs it should be possible to repeat the study
exactly, if necessary.
4. Results
 Raw data
All studies generate raw data. These are the outcome of research and form the basis for
establishing scientific interpretations and arriving at conclusions. The raw data must also
reflect the procedures and conditions of the study.
 Final Report
The study report contains an account of the way in which the study was performed,
incorporates the study results and includes the scientific interpretation of the data. The report
is provided to regulatory authorities as part of the submission for registration and marketing
approval.
 Archives
Storage of records must ensure safekeeping for many years and allow for prompt retrieval.
5. Quality Assurance
Quality assurance (QA), as defined by GLP, is a team of persons (often called the Quality
assurance unit – QAU) charged with assuring management that GLP compliance has been
attained within the laboratory. QA must be independent from scientists involved in the
operational aspects of the study being performed. QA functions as a witness to the whole
non-clinical research process.
THE OECD GLP PRINCIPLES
 GLP started when the FDA issued mandatory GLP requirements on 20 June 1979.
 the OECD introduced the OECD Principlesfor GLP (GLP Principles) concerning the safety
testing of any chemical substance.
 This GLP text is binding on all 30 OECD member states. This is why these GLP Principles have
been adopted as the basic rules for the training programme devised for the WHO/TDR.
 The OECD recognizes that not all parts of the GLP Principles are easy to interpret. This is why
the OECD has published a series of advisory documents on various aspects of the GLP
Principles.
 In all, there are 15 OECD documents concerning GLP (including the GLP Principles). Many of
these have been derived from discussions between regulators and members of industry
during consensus workshops.
 The contents of the documents represent the current thinking of the OECD.
 Any member state can request that a particular subject be discussed during a consensus
meeting.
 The OECD has established a GLP Group made up of senior members of the respective member
states’ GLP monitoring authorities.
 This group oversees the GLP activities of the OECD. The activities include the organization of
training courses for GLP inspectors from all over the world and the organization of joint
inspections. Together, these help to harmonize the approach of the various member states to
GLP inspections.
Fundamentals of OECD GLP Principles
Five Basic Points
1. Resources: =Personnel, Facilities & Equipment.
2. Characterization :=
Test Article - Identification, Quality ……
Test system - Identification, Health status
3. Rules := Protocols / Study Plans, Procedures
4. Results:= Raw data, Final Report, Archives.
5. Quality Assurance: =Audit/Inspection - Training – Advice.
Good laboratory practice

More Related Content

What's hot

Clinical Trial Management Systems
Clinical Trial Management SystemsClinical Trial Management Systems
Clinical Trial Management Systems
Deepak Yadav
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
SonaliJain736101
 

What's hot (20)

Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trial
 
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATIONCONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
 
Cdsco ppt
Cdsco pptCdsco ppt
Cdsco ppt
 
INVESTIGATIONAL NEW DRUG (IND)
INVESTIGATIONAL NEW DRUG (IND) INVESTIGATIONAL NEW DRUG (IND)
INVESTIGATIONAL NEW DRUG (IND)
 
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptxREGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
 
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
 
Institutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeInstitutional review board/Independent ethics Committee
Institutional review board/Independent ethics Committee
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
Clinical Trial Management Systems
Clinical Trial Management SystemsClinical Trial Management Systems
Clinical Trial Management Systems
 
Importance and application of toxicokinetics
Importance and application of toxicokineticsImportance and application of toxicokinetics
Importance and application of toxicokinetics
 
Institutional Review Board (IRB)/ Independent Ethics committee (IEC)
Institutional Review Board (IRB)/ Independent Ethics committee (IEC)Institutional Review Board (IRB)/ Independent Ethics committee (IEC)
Institutional Review Board (IRB)/ Independent Ethics committee (IEC)
 
Test item characterization
Test item characterizationTest item characterization
Test item characterization
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
Schedule Y
Schedule Y Schedule Y
Schedule Y
 
Schedule Y
Schedule YSchedule Y
Schedule Y
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]
 
Guidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsGuidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trials
 

Similar to Good laboratory practice

Similar to Good laboratory practice (20)

GLP.pdf
GLP.pdfGLP.pdf
GLP.pdf
 
GLP.pptx
GLP.pptxGLP.pptx
GLP.pptx
 
Introduction to good laboratory practices
Introduction to good laboratory practicesIntroduction to good laboratory practices
Introduction to good laboratory practices
 
GLP DRA.pptx
GLP DRA.pptxGLP DRA.pptx
GLP DRA.pptx
 
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxGOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
 
Glp
GlpGlp
Glp
 
Glp.
Glp.Glp.
Glp.
 
GLP and Schedule 1
GLP and Schedule 1GLP and Schedule 1
GLP and Schedule 1
 
Quality management systems: Good Laboratory Practice (QMS GLP)
Quality management systems: Good Laboratory Practice (QMS GLP)Quality management systems: Good Laboratory Practice (QMS GLP)
Quality management systems: Good Laboratory Practice (QMS GLP)
 
Quality management systems: Good Laboratory Practice (QMS GLP)
Quality management systems: Good Laboratory Practice (QMS GLP)Quality management systems: Good Laboratory Practice (QMS GLP)
Quality management systems: Good Laboratory Practice (QMS GLP)
 
WJPR 6039
WJPR 6039 WJPR 6039
WJPR 6039
 
Good laboratory practice
Good laboratory practiceGood laboratory practice
Good laboratory practice
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticals
 
GLP - Good Laboratory Practices
GLP - Good Laboratory PracticesGLP - Good Laboratory Practices
GLP - Good Laboratory Practices
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Glp seminar
Glp  seminarGlp  seminar
Glp seminar
 
Oecd principles of good laboratory practices (glp)
Oecd principles of good laboratory practices (glp)Oecd principles of good laboratory practices (glp)
Oecd principles of good laboratory practices (glp)
 
Good Laboratory Practices
Good Laboratory PracticesGood Laboratory Practices
Good Laboratory Practices
 
Glp
GlpGlp
Glp
 

More from ManjuJhakhar (9)

Schedule y.
Schedule y. Schedule y.
Schedule y.
 
Saturation kinetics.
Saturation kinetics.Saturation kinetics.
Saturation kinetics.
 
Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology
 
Plasma Protein Binding of Drugs in the Elderly
Plasma Protein Binding of Drugs in the ElderlyPlasma Protein Binding of Drugs in the Elderly
Plasma Protein Binding of Drugs in the Elderly
 
Immunosuppressants drug
Immunosuppressants drugImmunosuppressants drug
Immunosuppressants drug
 
Combinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discoveryCombinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discovery
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study team
 
Intercellular signalling pathways
Intercellular signalling pathwaysIntercellular signalling pathways
Intercellular signalling pathways
 
Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Recently uploaded (20)

Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 

Good laboratory practice

  • 1. Good Laboratory Practice Presented by: Manju Jakhar M.Pharm (Pharmacology) 2nd Semester
  • 2. INTRODUCTION • Good Laboratory Practice (GLP) regulations became part of the regulatory landscape in the latter part of the 1970s in response to malpractice in research and development (R&D) activities by pharmaceutical companies and contract facilities used by them. • The malpractice included cases of fraud, but by far the most important aspects were the lack of proper management and organization of studies performed to generate data fo regulatory dossiers. The US Food and Drug Administration (FDA) mounted a series of investigations in toxicology laboratories throughout the USA. The results of these investigations revealed a situation that could only be dealt with by imposing binding regulations. These regulations are the GLP regulations. • GLP regulations were first instituted by US FDA, then by US Environmental Protection Agency (EPA) many other nations have since followed suit. • FDA weekly update their data and they upload on their website. • In 1981, the Organization for Economic Cooperation and Development (OECD) also published GLP Principles.
  • 3. GLP WORK:- The intent of GLP is to regulate the practices of scientists working on the safety testing of prospective drugs (and other chemical or biochemical entities). THE FUNDAMENTAL POINTS OF GLP:- • The GLP regulations set out the rules for good practice and help researchers perform their work in compliance with their own pre-established plans and standardized procedures. The regulations are not concerned with the scientific or technical content of the research programmes. Nor do they aim to evaluate the scientific value of the studies. • All GLP texts, irrespective of their origin, stress the importance on the following points five points: 1. Resources: organization, personnel, facilities and equipment 2. Characterization: test items and test systems 3. Rules: study plans (or protocols) and written procedures 4. Results: raw data, final report and archives 5. Quality Assurance. The training programme of the WHO covers each of these five fundamental points and explains the requirements of GLP in each case.
  • 4. 1. Resources  Organization and personnel GLP regulations require that the structure of R&D organizations and the responsibilities of R&D personnel be clearly defined. GLP also stresses that there should be sufficient staff to perform the tasks required. The qualifications and the training of staff must also be defined and documented.  Facilities and equipment The regulations emphasize the need for sufficient facilities and equipment to perform the studies. All equipment must be in working order. To ensure this, a strict programme of qualification, calibration and maintenance must be adopted. 2. Characterization In order to perform a study correctly, it is essential to know as much as possible about the materials used during the study. For studies that evaluate the properties of pharmaceutical compounds during non-clinical studies, it is a prerequisite to have details about the test item and the test system (often an animal or plant) to which the test item is to be administered. 3. Rules  Protocols and written procedures The main steps of research studies are prescribed in the study plan or protocol. Being able to repeat studies and obtain similar results is a sine qua non of mutual acceptance of data and, indeed, a central tenet of the scientific method, so the details of routine procedures must also be available to scientists involved in the study. However, the protocol, which provides the experimental design and timeframe for the study, does not contain all the technical detail necessary to conduct the study. These details are found in written standard operating procedures (SOPs). With the protocol and the SOPs it should be possible to repeat the study exactly, if necessary.
  • 5. 4. Results  Raw data All studies generate raw data. These are the outcome of research and form the basis for establishing scientific interpretations and arriving at conclusions. The raw data must also reflect the procedures and conditions of the study.  Final Report The study report contains an account of the way in which the study was performed, incorporates the study results and includes the scientific interpretation of the data. The report is provided to regulatory authorities as part of the submission for registration and marketing approval.  Archives Storage of records must ensure safekeeping for many years and allow for prompt retrieval. 5. Quality Assurance Quality assurance (QA), as defined by GLP, is a team of persons (often called the Quality assurance unit – QAU) charged with assuring management that GLP compliance has been attained within the laboratory. QA must be independent from scientists involved in the operational aspects of the study being performed. QA functions as a witness to the whole non-clinical research process.
  • 6. THE OECD GLP PRINCIPLES  GLP started when the FDA issued mandatory GLP requirements on 20 June 1979.  the OECD introduced the OECD Principlesfor GLP (GLP Principles) concerning the safety testing of any chemical substance.  This GLP text is binding on all 30 OECD member states. This is why these GLP Principles have been adopted as the basic rules for the training programme devised for the WHO/TDR.  The OECD recognizes that not all parts of the GLP Principles are easy to interpret. This is why the OECD has published a series of advisory documents on various aspects of the GLP Principles.  In all, there are 15 OECD documents concerning GLP (including the GLP Principles). Many of these have been derived from discussions between regulators and members of industry during consensus workshops.  The contents of the documents represent the current thinking of the OECD.  Any member state can request that a particular subject be discussed during a consensus meeting.  The OECD has established a GLP Group made up of senior members of the respective member states’ GLP monitoring authorities.
  • 7.  This group oversees the GLP activities of the OECD. The activities include the organization of training courses for GLP inspectors from all over the world and the organization of joint inspections. Together, these help to harmonize the approach of the various member states to GLP inspections. Fundamentals of OECD GLP Principles Five Basic Points 1. Resources: =Personnel, Facilities & Equipment. 2. Characterization := Test Article - Identification, Quality …… Test system - Identification, Health status 3. Rules := Protocols / Study Plans, Procedures 4. Results:= Raw data, Final Report, Archives. 5. Quality Assurance: =Audit/Inspection - Training – Advice.